Stem Cell Sciences has a substantial portfolio of patents and patent applications in both adult and embryonic stem cell fields. The Company has been active in the stem cell research field since 1994, principally focused on technologies to grow, differentiate, and purify adult and embryonic stem cells. These include technologies to permit the generation of highly purified stem cells and their differentiated progeny (specialised tissue cell types) for use in genetic, pharmacological and toxicological screens. Moreover, these technologies may be able to provide pure populations of appropriate cell types for transplantation therapies in the future.
The Company has its main research base and headquarters in Cambridge, UK with a second research base in Monash near Melbourne, Australia and a business development office in San Francisco, USA.
For further information on the company please visit:
For further information, please contact:
Stem Cell Sciences plc (United Kingdom)
Alastair Riddell, CEO
Tim Allsopp, Chief Scientific Officer
Stem Cell Sciences pty ltd (Australia)
Paul Bello, Operations Manager
Citigate Dewe Rogerson (UK)
Mark Swallow / Emma Palmer Foster / Amber Bielecka
Talk Biotech (Australia)
Fay Weston, Director
Daniel Stewart & Company (NOMAD to SCS, UK)
Simon Leathers / Simon Starr
|SOURCE Stem Cell Sciences plc|
Copyright©2008 PR Newswire.
All rights reserved